Windtree Therapeutics Files 8-K with Material Agreements
Ticker: WINTW · Form: 8-K · Filed: May 1, 2025 · CIK: 946486
| Field | Detail |
|---|---|
| Company | Windtree Therapeutics Inc /De/ (WINTW) |
| Form Type | 8-K |
| Filed Date | May 1, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: material-agreement, corporate-action, filing
TL;DR
Windtree Therapeutics filed an 8-K on 4/30/25 detailing material agreements and changes to security holder rights.
AI Summary
On April 30, 2025, Windtree Therapeutics, Inc. entered into a material definitive agreement. The company also made material modifications to the rights of its security holders and amended its articles of incorporation or bylaws. These actions were disclosed under Regulation FD and included financial statements and exhibits.
Why It Matters
This filing indicates significant corporate actions and potential changes affecting Windtree Therapeutics' structure and security holders.
Risk Assessment
Risk Level: medium — Material definitive agreements and modifications to security holder rights can introduce significant changes and potential risks for investors.
Key Players & Entities
- Windtree Therapeutics, Inc. (company) — Registrant
- April 30, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
FAQ
What specific material definitive agreement did Windtree Therapeutics enter into?
The filing does not specify the exact nature of the material definitive agreement, only that one was entered into on April 30, 2025.
What were the material modifications to the rights of security holders?
The filing indicates material modifications were made to the rights of security holders, but the specific details of these modifications are not provided in the summary information.
Were there any amendments to Windtree Therapeutics' articles of incorporation or bylaws?
Yes, the filing states that there were amendments to the articles of incorporation or bylaws.
What is the SIC code for Windtree Therapeutics, Inc.?
The Standard Industrial Classification (SIC) code for Windtree Therapeutics, Inc. is 2836, which corresponds to Biological Products (No Diagnostic Substances).
When is Windtree Therapeutics' fiscal year end?
Windtree Therapeutics' fiscal year ends on December 31st.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 1, 2025 regarding WINDTREE THERAPEUTICS INC /DE/ (WINTW).